Benefits
PMS symptom relief
Meta-analyses of 7 RCTs confirm chasteberry significantly reduces PMS symptoms across all domains — physical (bloating, breast tenderness, headache), behavioral (irritability, mood swings), and psychological (anxiety, depression) — with response rates of 50–80% in placebo-controlled trials. Effects are consistent across multiple standardized extract forms.
Cyclical mastalgia relief
Chasteberry is the most evidence-based natural treatment for cyclical breast pain (mastalgia) — a common and distressing PMS symptom. Multiple RCTs show significant reductions in breast pain scores with chasteberry extracts, with a head-to-head trial showing equivalent efficacy to bromocriptine (a dopamine agonist drug) with dramatically better tolerability.
Prolactin normalization and hormone balance
The dopamine agonist mechanism of chasteberry reduces elevated prolactin levels (latent hyperprolactinemia) — a key driver of luteal phase insufficiency, PMS symptoms, and irregular menstrual cycles. By restoring normal prolactin levels, chasteberry improves progesterone production in the luteal phase and stabilizes the menstrual cycle.
Irregular menstrual cycle regulation
Chasteberry reduces the frequency and severity of oligomenorrhea (infrequent periods), amenorrhea (absent periods), and polymenorrhea (very frequent periods) through HPG axis dopaminergic modulation. Clinical studies show improvement in cycle regularity within 3–6 cycles of treatment.
Mechanism of action
Dopamine D2 receptor agonism and prolactin suppression
Chasteberry diterpenes (particularly rotundifuran) bind dopamine D2 receptors on pituitary lactotroph cells, inhibiting prolactin secretion. Since prolactin excess drives luteal phase insufficiency, breast pain, and many PMS symptoms, this dopaminergic mechanism directly addresses the hormonal imbalance underlying PMS rather than just managing symptoms.
Mu-opioid receptor partial agonism
Casticin and other chasteberry flavonoids show partial agonist activity at mu-opioid receptors in the CNS — contributing to analgesic and mood-stabilizing effects that complement the dopaminergic mechanism. This opioid pathway modulation may explain PMS-associated pain relief beyond prolactin reduction.
Progesterone receptor expression upregulation
By reducing prolactin and improving luteal phase function, chasteberry indirectly increases progesterone receptor expression and progesterone signaling in the second half of the menstrual cycle — correcting the estrogen-progesterone imbalance that drives many PMS symptoms.
Clinical trials
Evidence review and pooled analysis of randomized, double-blind, placebo-controlled trials examining Vitex agnus-castus extract for premenstrual syndrome. (Am J Obstet Gynecol; or 2015 review by van Die et al.)
Pooled across multiple trials.
Vitex agnus-castus significantly more effective than placebo for overall PMS symptom reduction. Notable for breast tenderness, mood symptoms, and irritability. Effect sizes meaningful for moderate PMS. Note: heterogeneity in extract types and doses limits precise effect estimation; standardized extracts (Ze 440, Premular) have the strongest evidence.
Randomized, double-blind trial of chasteberry (Ze 440, 20 mg/day) vs bromocriptine (5 mg/day) vs placebo in women with cyclical mastalgia. (Breast)
Women with cyclical mastalgia (cyclic breast pain).
Chasteberry produced equivalent breast pain reduction to bromocriptine (a dopamine agonist drug) with substantially better tolerability — bromocriptine commonly causes nausea and dizziness, while chasteberry was as well-tolerated as placebo. Note: bromocriptine is rarely used today for mastalgia due to its side effect profile; chasteberry is positioned as a gentler alternative.